AMP Concerned about the Structure and Application of Gap Fill Payment Amounts
The Association for Molecular Pathology (AMP) submitted comments to the Centers for Medicare and Medicaid Services (CMS) expressing serious concerns about the gap fill process.
View ArticleThe Association for Molecular Pathology Announces Award Recipients for 2013
The Association for Molecular Pathology (AMP) proudly announces its slate of award winners for 2013. Each recipient was carefully vetted and selected by a distinguished group of AMP leadership.
View ArticleThe Association for Molecular Pathology Announces Highlights of Phoenix Meeting
. The event, to be held November 14-16 at the Phoenix Convention Center in Phoenix, AZ will highlight an array of topics focusing on genomics, proteomics, informatics, reimbursement, and optimization...
View ArticleThe Association for Molecular Pathology Releases Position Statement on LDTs
: The Association for Molecular Pathology (AMP) released a special article in the January 2014 issue of The Journal of Molecular Diagnostics titled "Revisiting Oversight and Regulation of...
View ArticleAMP Publishes Curriculum Recommendations for Medical Laboratory Scientists
The Association for Molecular Pathology (AMP) released a report today in The Journal of Molecular Diagnostics on recommendations for a molecular diagnostics curriculum at both the baccalaureate and...
View ArticleAMP Celebrates the Contributions of Medical Laboratory Professionals during...
The Association for Molecular Pathology (AMP) joins the American Society for Clinical Pathology (ASCP) to celebrate the vital role laboratory professionals and pathologists play in health care.
View ArticleFrancis S. Collins, MD, PhD, to Speak at AMP 2014 Annual Meeting
The Association for Molecular Pathology (AMP) announced today that Francis S. Collins, MD, PhD, Director of the National Institutes of Health (NIH), will give a special address at the AMP 2014 Annual...
View ArticleThe Association for Molecular Pathology Voices Concern with U.S. FDA...
AMP today reaffirmed its position that the vast majority of laboratory developed procedures should continue operating under the regulation of the CLIA program at the CMS and not be subject to...
View ArticleThe Association for Molecular Pathology Adds Late-Breaking Session on...
AMP's late-breaking session, titled, "Framework for Oversight of LDTs: A Conversation with FDA" is scheduled for Thursday, November 13, 2014 at 1:00pm EST. Immediately following, AMP will host a press...
View ArticleAMP Launches Informatics Subdivision
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals around the world announced the creation of an Informatics Subdivision...
View ArticleThe Association for Molecular Pathology Announces 2014 Award Recipients
AMP announced its 2014 award winners. Recipients of the Award for Excellence in Molecular Diagnostics, Jeffrey A. Kant Leadership Award, and AMP Meritorious Service Award were presented at the AMP...
View ArticleAMP has Strong Presence at FDA Workshop on LDTs, Delivers Message of...
The Association for Molecular Pathology (AMP), the premier global, non-profit organization serving molecular testing professionals, will speak at the U.S. Food and Drug Administration's (FDA) Public...
View ArticleAMP Releases "Molecular Diagnostic Perfect Storm" Paper Addressing the...
By eliminating the barriers outlined in "The Perfect Storm" paper, genome-based research will continue to play a critical role in the development of more powerful tools to treat complex diseases such...
View ArticleAMP Delivers Oral Comments at FDA Workshop on Optimizing Regulatory Oversight...
AMP presented at the U.S. Food and Drug Administration public workshop, "Optimizing FDA's Regulatory Oversight of Next Generation Sequencing Diagnostic Tests," outlining specific ways that FDA could...
View ArticleAMP Launches Micro-Costing and Health Economic Evaluation Tools for Genome...
AMP releases cost analysis results and health economic evaluation models for several genomic sequencing procedure codes.
View ArticleAMP Submits Written Comments to FDA on Next Generation Sequencing Regulation
AMP urged FDA to focus its attention on helping to ensure the performance characteristics of next generation sequencing (NGS) instruments, reagents, and related software. AMP further recommended that...
View ArticleASCP, CAP, AMP, and ASCO Issue Draft Colorectal Cancer Molecular Marker...
The American Society for Clinical Pathology (ASCP), the College of American Pathologists (CAP), the Association for Molecular Pathology (AMP), and the American Society of Clinical Oncology (ASCO) today...
View ArticleThe Association for Molecular Pathology Compiles Current Research on Liquid...
In general, the article supports the notion that this type of diagnostic testing in and of itself allows for earlier diagnosis, faster and more targeted treatment, reduced costs, and increased quality...
View ArticleThe Association for Molecular Pathology Announces International Affairs...
The work of the IAC began in 2010 with the formation of the International Affairs Working Group. Since that time, the group has successfully collaborated to form four AMP International Affiliate...
View ArticleThe Evolving Role of the Laboratory Professional in the Age of Genomic...
The article describes the current and future roles of the laboratory professional as genomic sequencing analysis becomes an ever more increasingly important tool in diagnostic medicine.
View Article